Leukemia cells lacking PTEN reveal a metabolic weakness that approved drugs can exploit
Loss of PTEN makes T-cell acute lymphoblastic leukemia cells dependent on the guanylate-synthesis enzyme IMPDH, allowing clinically approved IMPDH inhibitors ...
Loss of PTEN makes T-cell acute lymphoblastic leukemia cells dependent on the guanylate-synthesis enzyme IMPDH, allowing clinically approved IMPDH inhibitors ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.